4//SEC Filing
ZIMMERMAN DANIEL H 4
Accession 0001236215-21-000014
CIK 0000725363other
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 9:29 AM ET
Size
5.6 KB
Accession
0001236215-21-000014
Insider Transaction Report
Form 4
CEL SCI CORPCVM
ZIMMERMAN DANIEL H
Sr Vice President
Transactions
- Award
Options
2021-11-19$0.01/sh+50,000$500→ 753,253 totalExercise: $10.48Exp: 2031-11-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.
Documents
Issuer
CEL SCI CORP
CIK 0000725363
Entity typeother
Related Parties
1- filerCIK 0001236028
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 9:29 AM ET
- Size
- 5.6 KB